Table of Content

1. Introduction to Transdermal Patch
1.1 Overview of Transdermal Patch
1.2 Relevance of Transdermal Patch


2. Transdermal Patches Classification
2.1 Single/ Multiple-Layer Drug-in-Adhesive
2.2 Reservoir Transdermal Patches
2.3 Matrix Based Transdermal Patches
2.4 Vapor Patch
2.5 Active and Passive Patch


3. Mechanism of Transdermal Patch Drug Delivery
3.1 Properties of Transdermal Therapeutics
3.2 Components of Transdermal Patch
3.3 Mechanism of Motion Sickness, Nicotine & Female Contraceptive Transdermal Patch
3.4 Transdermal Patch v/s Traditional Drug Delivery Methods


4. Global Transdermal Patch Market Outlook
4.1 Current Market Scenario
4.2 Future Market Opportunity


5. Global Transdermal Patch Market Trends by Region
5.1 US
5.2 Europe
5.3 China
5.4 Japan
5.5 South Korea
5.6 UK


6. Transdermal Patches for Cardiovascular Diseases – Market Availability, Dosage & Price Analysis
6.1 Nitro Glycerin Transdermal Patch
6.1.1 Nitro-Dur
6.1.2 Nitro TD Patch A
6.1.3 Generic Nitroglycerine Trandsdermal Patch
6.2 Clonidine Transdermal Patch (Catapres–TTS)


7. Opioid Drug Containing Transdermal Patches - Market Availability, Dosage & Price Analysis
7.1 Fentanyl Transdermal Patch
7.2 Buprenorphine Transdermal Patch
7.2.1 Butrans Patch
7.2.2 Bunov


8. Transdermal Patch in Hormonal Therapy - Market Availability, Dosage & Price Analysis
8.1 Estradiol Transdermal Patch
8.1.1 Alora
8.1.2 Vivelle-Dot
8.1.3 Minivelle
8.1.4 Climara
8.1.5 Menostar
8.1.6 Femseven
8.1.7 Generic Estradiol Transdermal Patch
8.2 Testosterone Transdermal Patch (Androderm)
8.3 Estradiol & NorethindroneTransdermal Patch
8.3.1 Xulane/Ortho Evra
8.3.2 Combipatch
8.4 Estradiol/Levonorgestrel Transdermal Patch
8.5 Ethinyl Estradiol/Levonorgestrel (Twirla)


9. Transdermal Patches for Neurological Disorders - Market Availability, Dosage & Price Analysis
9.1 Scopolamine Transdermal Patch (Transderm-Scop)
9.2 Selegiline Transdermal Patch (Emsam)
9.3 Methylphenidate Transdermal Patch (Daytrana)
9.4 Asenapine Transdermal Patch (Secuado)
9.5 Rivastigmine Transdermal Patch (Exelon)
9.6 Rotigotine Transdermal Patch (Neupro)
9.7 Ropinirole Hydrochloride (Haruropi Tape)


10. Transdermal Patches for Other Conditions - Market Availability, Dosage & Price Analysis
10.1 Nicotine Transdermal Patch (Nicoderm CQ/ Nicotinell TTS)
10.2 Oxybutynin Transdermal Patch (Oxytrol/Kentera)
10.3 Sancuso (Granisetron)
10.4 Methyl Salicate (Salonpas)
10.5 Bisono


11. Global Transdermal Patch Clinical Pipeline Overview
11.1 By Phase
11.2 By Region/Country
11.3 By Drug Class/Molecule
11.4 By Company
11.5 By Orphan & Fast Track Status


12. Global Patch Clinical Pipeline By Company, Indication & Phase
12.1 Unknown
12.2 Research
12.3 Preclinical
12.4 Clinical
12.5 Phase-I
12.6 Phase-I/II
12.7 Phase-II
12.8 Phase-III
12.9 Preregistration
12.10 Registered


13. Marketed Transdermal Patch Clinical Insight


14. Global Transdermal Patch Market Dynamics
14.1 Favorable Market Parameters
14.2 Commercialization Challenges


15. Global Transdermal Patch Market Future Outlook 2028


16. Competitive Landscape
16.1 3M Pharmaceuticals
16.2 Acrux
16.3 Agile Therapeutics
16.4 Allergan
16.5 ANI Pharmaceuticals
16.6 Antares Pharma
16.7 Bayer HealthCare Pharmaceuticals
16.8 Corium International
16.9 Chase Pharmaceuticals
16.10 DURECT Corporation
16.11 Endo Pharmaceuticals
16.12 Fempharm
16.13 Hisamitsu Pharmaceutical
16.14 Immune Pharmaceuticals
16.15 Imprimis Pharmaceuticals
16.16 Ipsen Bioscience
16.17 Johnson & Johnson
16.18 LaSalle Laboratories
16.19 Lavipharm-increase
16.20 Luye Pharma
16.21 MINRAD International
16.22 NeurogesX
16.23 Noven Pharmaceuticals
16.24 NuPathe
16.25 Nuvo Research
16.26 Novartis
16.27 Pain Therapeutics
16.28 ProStrakan
16.29 Purdue Pharma
16.30 Sanofi
16.31 Scilex Pharmaceuticals
16.32 Senju Pharmaceutical
16.33 Somerset Pharmaceuticals
16.34 Teikoku Seiyaku
16.35 Therapeutic Discovery Corporation
16.36 Transdermal Delivery Solutions Corp
16.37 UCB
16.38 Xel Pharmaceuticals
16.39 Zosano Pharma